TransMedics Group Inc - Asset Resilience Ratio
TransMedics Group Inc (TMDX) has an Asset Resilience Ratio of 0.00% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2006–2022)
This chart shows how TransMedics Group Inc's Asset Resilience Ratio has changed over time. Check TransMedics Group Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down TransMedics Group Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see TransMedics Group Inc (TMDX) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: TransMedics Group Inc maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
TransMedics Group Inc Industry Peers by Asset Resilience Ratio
Compare TransMedics Group Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.30% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
Novacyt
PA:ALNOV |
Medical Devices | 0.02% |
|
Implanet SA
PA:ALIMP |
Medical Devices | 0.55% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Annual Asset Resilience Ratio for TransMedics Group Inc (2006–2022)
The table below shows the annual Asset Resilience Ratio data for TransMedics Group Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 0.00% | $0.00 | $277.15 Million | -- |
| 2021-12-31 | 49.57% | $66.87 Million | $134.89 Million | -16.90pp |
| 2020-12-31 | 66.48% | $101.06 Million | $152.03 Million | +8.93pp |
| 2019-12-31 | 57.55% | $60.60 Million | $105.30 Million | -- |
| 2018-12-31 | 0.00% | $0.00 | $42.16 Million | -- |
| 2017-12-31 | 34.40% | $12.73 Million | $37.00 Million | -31.01pp |
| 2016-12-31 | 65.40% | $38.00 Million | $58.10 Million | +46.61pp |
| 2006-12-31 | 18.79% | $2.80 Million | $14.90 Million | -- |
About TransMedics Group Inc
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic con… Read more